Millennium Management’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1
Closed -$6.49K 6350
2023
Q4
$6.49K Buy
+1
New +$11.5K ﹤0.01% 5786
2023
Q1
Sell
-1
Closed -$46K 6541
2022
Q4
$46K Sell
1
-2
-67% -$113K ﹤0.01% 5799
2022
Q3
$203K Hold
3
﹤0.01% 5652
2022
Q2
$179K Sell
3
-2
-40% -$141K ﹤0.01% 5687
2022
Q1
$485K Sell
5
-5
-50% -$488K ﹤0.01% 5148
2021
Q4
$582K Buy
10
+3
+43% +$250K ﹤0.01% 4917
2021
Q3
$870K Sell
7
-4
-36% -$518K ﹤0.01% 4833
2021
Q2
$1.61M Buy
11
+8
+267% +$1.31M ﹤0.01% 4198
2021
Q1
$547K Buy
+3
New +$659K ﹤0.01% 4751
2020
Q2
Sell
-1
Closed -$105K 4311
2020
Q1
$105K Buy
+1
New +$103K ﹤0.01% 3541

Other funds holding GNPX

Millennium Management's GNPX Position: Q1 2024 in Review

Millennium Management sold out of Genprex (GNPX) in Q1 2024, closing a stake of 1 share — an estimated $6.49K sold.

Millennium Management first reported a position in GNPX in Q1 2020 and held it in 10 quarters. The position peaked at $1.61M in Q2 2021. 8 funds tracked by Wall St. Rank hold GNPX as of Q1 2024.

  • Millennium Management reported no remaining Genprex position as of Q1 2024 after selling out during the quarter.
  • Millennium Management sold 1 Genprex share in Q1 2024, an estimated $6.49K.
  • Millennium Management first reported a position in Genprex in Q1 2020 and held it in 10 quarters.
  • Millennium Management's Genprex position peaked at $1.61M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Genprex as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.